Cynata Therapeutics and Japan’s Regience K.K. in stem cell alliance – Proactive Investors Australia
|
Cynata Therapeutics and Japan's Regience K.K. in stem cell alliance
Proactive Investors Australia The Cymerus stem cell technology provides a source of MSCs that is independent of donor limitations and provides a potential “off-the-shelf” stem cell platform for therapeutic product use, with a pharmaceutical business model and economies of scale. Cynata Enters Agreement for Strategic Alliance in Japan |
